Astoriom expands global footprint for sample stability storage services
Growth in dedicated sample stability facilities at Tramore (Ireland) site to meet demand for flexible, regulatory-compliant storage solutions
ELRIG announces keynote speakers for Drug Discovery 2025
Prof Heather Pinkett and Dr Dafydd Owen to lead ELRIG’s flagship event Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate “A Festival of Life Science”Event supported by VisitBritain showcases UK life science sector and extends interna
Astoriom appoints Ryan Smith as Global Head of Sales
Key appointment to support company in scaling biorepository and stability storage operations
ELRIG appoints Dr Del Trezise as Chair
Cambridge, UK, 8 April 2025: ELRIG, a not-for-profit, volunteer-led organisation dedicated to the drug discovery community, has appointed Dr Del Trezise as Chair of the Board.
ELRIG announces Prof Rory Johnson and Dr Shalini Andersson as Keynote Speakers at Therapeutic Oligonucleotides 2025
Therapeutic Oligonucleotides 2025: Drugging the Undruggable takes place at AstraZeneca in Gothenburg, Sweden from 14–15 May
Yourgene Health launches IONA Care+ Non-invasive Prenatal Testing Service
Offers expectant parents fully comprehensive prenatal screening test for genetic conditions, including microdeletions
Glox Therapeutics strengthens team appointing Dr Michael Murray as Chair and Dr Nel Moore as Scientific Advisory Board Member
Expanded team to support development and commercialisation of precision antibiotics to help overcome antimicrobial resistance
ELRIG announces Drs Jue Wang and Robert Grundy as keynote speakers at Research & Innovation 2025
• ELRIG Research & Innovation 2025 takes place in London, UK from 10–11 March • Event will focus on ‘Big molecules to big data…thinking BIG to drive innovative research’
Glox Therapeutics awarded share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate
£500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in people with cystic fibrosisProgramme delivered by CF AMR Syndicate offers cross-sector collaboration and support to address urgent un
Glox Therapeutics awarded £1M PACE grant to accelerate development of precision antibiotics against antimicrobial-resistant pathogens
Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae PACE provides funding and support for innovative, high value, high risk, early phase drug discovery and diagnostic projects
Primerdesign launches new animal multiplex assays at London Vet Show
Rapid, accurate detection of six gastrointestinal disease-causing pathogens in cats and dogs.
Yourgene Health Cystic Fibrosis Base assay receives IVDR accreditation
Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, announces that it has received accreditation under the new EU requirements of the in vitro diagnostic regulation (IVDR) for the Yourgene® Cystic Fibrosis Base
Yourgene Health and Genetix launch first local non-invasive prenatal testing service in Colombia
Genetix will utilise Yourgene Health’s IONA Nx NIPT Workflow to deliver first NIPT service in region Service offers safe, fast and accurate prenatal testing to expectant parentsManchester, UK, and Bogotá, Colombia, 2 October 2024:
ELRIG UK and The Protein Society partner to advance protein sciences in drug discovery
Cambridge, UK and Los Angeles, US: The European Laboratory Research & Innovation Group (ELRIG) UK, a not-for-profit, volunteer-led organisation for the drug discovery community, has partnered with The Protein Society (TPS), an international, not-for-profit, scholarly society,
Primerdesign launches real-time PCR workflow for onsite detection of Norovirus in Oysters
genesig Easy_oys Detection Kit offers rapid and reliable qPCR workflow to quantify Norovirus GI and GII pathogens in oyster tissue Onsite analysis helps ensure shellfish quality and safety across the production line, reducing public health risk DeELRIG UK announces Profs Ijeoma Uchegbu and Marcus Schindler as Keynote Speakers at Drug Discovery 2024
Drug Discovery 2024: Connecting Minds, Transforming Science, Empowering Community will take place at ExCeL London from 2–3 October
ELRIG UK and SRG announce partnership to advance life science professionals in drug discovery
Partnership endorses mission to facilitate career progression and support life science industry growth.
CryoLogyx completes £500k seed funding round
Funding round led by private UK business angels and the Wider Oxford Technology Angel Network Investment to support commercialization of pre-plated, assay-ready, cryopreserved cells for drug discovery, diagnostic and cell therapy applications CryELRIG UK announces Steve Bates and Dr Anderson Ryan as Keynote Speakers at Research and Innovation 2024
ELRIG Research and Innovation 2024 takes place from 20–21 March in Manchester, UK Key topics include oncology, antimicrobial resistance, mass spectrometry, proteomics and animal-free drug discovery Launch of TechBio Breakthrough Zone offers youngYourgene Health becomes a PacBio Compatible Partner: enabling PacBio customers to optimise size selection for long-read sequencing libraries
Yourgene’s LightBench® instrument offers precise and accurate size selection of PacBio® SMRTbell® sequencing libraries increasing HiFi sequencing yields
Glox Therapeutics secures £4.3M seed funding to develop precision antimicrobials targeting drug-resistant bacteria
Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria
Yourgene Health and Laboriad launch non-invasive prenatal testing in Morocco
Yourgene Health installs first NIPT platform, the IONA test, in Morrocco, enabling Laboriad to offer safe, fast and accurate prenatal testing to expectant parents
ELRIG UK establishes Engagement Strategy Work Group
Cambridge, UK, 14 September 2023: The European Laboratory Research & Innovation Group (ELRIG) UK announces the formation of its Engagement Strategy Work Group (ESWG).
Yourgene Health launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows
Offers clinical labs in APAC and Middle East cost-efficient, bench-top robotic cell-free DNA extraction workstation and reagents for Yourgene’s Sage 32 NIPT Workflow.
TherageniX and University of Nottingham Awarded £995K Innovate UK grant to develop powdered gene therapy for bone regeneration
London, UK, and Nottingham, UK - TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation agency. The funding will support the development of the Company’s gene therapy in a powder, a non-viral gene…